News

News-Medical.Net on MSN12d
CHAF1B drives lung squamous cell carcinoma progression by repressing SETD7
CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and ...
SurvivorNet on MSN6h
A Promising New Option For PIK3CA-Mutated Breast Cancer: What New Data On Inavolisib Could Mean for You
Inavolisib (Itovebi) is a new targeted therapy for HR+ HER2-negative metastatic breast cancer with a PIK3CA mutation.
AlphaGalileo12d
CHAF1B promotes the progression of lung squamous-cell carcinoma by inhibiting SETD7 expression
CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and ...
Targeted Oncology13d
FDA Grants Priority Review for Lurbinectedin/Atezolizumab in ES-SCLC
The FDA granted priority review to the combination of lurbinectedin and atezolizumab as a first-line maintenance therapy for ...
Stocktwits on MSN3d
Capricor Stock Slumps 16% On Report Of Key FDA Executive’s Removal, But Retail’s Hopeful About New 4-Year Deramiocel Data
Shares of Capricor Therapeutics (CAPR) tumbled 16% on Friday morning following reports that Nicole Verdun, director of the ...
Mirage News7d
Single-Cell RNA Sequencing Sheds Light on Tumor Diversity
Tumors are complex systems characterized by variations across genetic, transcriptomic, phenotypic, and microenvironmental ...
CURE12d
FDA Grants Priority Review to Zepzelca Combo for Small Cell Lung Cancer
FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.
The American Journal of Managed Care10d
Immunotherapy Timing Does Not Significantly Affect Outcomes in ES-SCLC
The timing of immunotherapy initiation is not a significant factor in the outcomes of patients with extensive-stage small ...
Genentech’s Lunsumio and Polivy Combination Significantly Prolongs Remission for People With Relapsed or Refractory Large B-cell Lymphoma
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today results from the Phase III SUNMO ...
Medscape10d
Hidradenitis Suppurativa Genetics Point Toward the Hair Growth Cycle
Genetic research, single-cell RNA sequencing, and spatial transcriptomics suggest that a prolonged anagen stage in the ...
Business Wire24d
Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small ...
At the prespecified primary data analysis, ivonescimab in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival ...